鼻渊合剂及其拆方干预急性鼻窦炎证型转化的特征及机制研究OA
Characteristics and Mechanisms of Biyuan Heji and Its Disassembled Formulas in Intervening the Syndrome Transformation of Acute Rhinosinusitis
目的 探讨鼻渊合剂及其拆方对急性鼻窦炎(ARS)由"风寒"为主向"肺热"为主证型转化的干预特征及可能机制.方法 将 144 只SD大鼠随机分为空白组、模型组、鼻渊合剂组、祛风寒组、清肺热组、西药组.除空白组外,其余各组均采用膨胀海绵联合金黄色葡萄球菌的方法造模.连续灌胃给药7 天,于给药前及给药后第 3、7、14 天观察行为学、组织病理及超微结构变化,采用免疫组化(IHC)、ELISA、Western blot及RT-qPCR法检测相关炎症因子、信号通路及缺氧因子表达.结果 模型组鼻黏膜上皮结构紊乱、炎症细胞浸润显著;各治疗组炎症反应均缓解,以鼻渊合剂组和西药组变化最明显.祛风寒组给药后第 3 天改善明显,清肺热组于第 7 天作用显著.与模型组比较,治疗组可不同程度下调肿瘤坏死因子-α(TNF-α)、细胞间黏附分子-1(ICAM-1)、白细胞介素(IL)-1β、IL-6、IL-8、IL-10、IL-12 表达,改善上皮超微结构,降低磷酸化p38 丝裂原活化蛋白激酶/总p38(p-p38/p38)比值及磷酸化核因子(NF)-κB p65 亚基/总p65(p-p65/p65)比值.模型组HIF-1α和VEGF的mRNA表达水平于第 7 天达峰.鼻渊合剂与西药自第3 天起即显著抑制其基因表达;祛风寒组在早期(3~7 天)抑制作用更为突出,而清肺热组在后期(7~14 天)更具优势.结论 本研究证实拆方祛风寒组、清肺热组分别在早期与后期发挥优势,并揭示其与炎症因子、HIF-1α及VEGF等指标变化密切相关.鼻渊合剂可能通过调控p38 丝裂原活化蛋白激酶(p38 MAPK)/NF-κB信号通路,干预ARS从"风寒"为主向"肺热"为主的证型演变.
Objective To investigate the intervention characteristics and potential mechanisms of Biyuan Heji and its disassembled formulas on the syndrome transformation of acute rhinosinusitis(ARS)from"wind-cold"dominance to"lung heat"dominance.Methods One hundred and forty-four SD rats were randomly divided into six groups:control group,model group,Biyuan Heji group,wind-cold dispelling group,lung heat clearing group,and Western medicine group.Except for the control group,all other groups were modeled using an expanded sponge combined with Staphylococcus aureus.After seven consecutive days of intragastric administration,behavioral,histopathological,and ultrastructural changes were observed before administration and on days 3,7,and 14 post-administration.Immunohistochemistry(IHC),ELISA,Western blot,and RT-qPCR were used to detect the expression of related inflammatory factors,signaling pathways,and hypoxia factors.Results The model group exhibited disordered nasal mucosal epithelial structure and significant inflammatory cell infiltration.All treatment groups showed alleviated inflammatory responses,with the Biyuan Heji group and Western medicine group demonstrating the most pronounced changes.The wind-cold dispelling group showed significant improvement on day 3 post-administration,while the lung heat clearing group exhibited notable effects on day 7.Compared with the model group,the treatment groups downregulated the expression of tumor necrosis factor-α(TNF-α),intercellular adhesion molecule-1(ICAM-1),interleukin(IL)-1β,IL-6,IL-8,IL-10,and IL-12 to varying degrees,improved epithelial ultrastructure,and reduced the ratios of phosphorylated p38 mitogen-activated protein kinase to total p38(p-p38/p38)and phosphorylated nuclear factor-κB(NF-κB)p65 subunit to total p65(p-p65/p65).The mRNA expression levels of HIF-1α and VEGF in the model group peaked on day 7.Biyuan Heji and Western medicine significantly inhibited their gene expression from day 3 onward.The wind-cold dispelling group showed more prominent inhibitory effects in the early stage(days 3-7),while the lung heat clearing group demonstrated greater advantages in the later stage(days 7-14).Conclusion This study confirmed that the disassembled wind-cold dispelling group and lung heat clearing group exerted their advantages in the early and later stages,respectively,and revealed their close association with changes in inflammatory factors,HIF-1α,and VEGF.Biyuan Heji may intervene in the syndrome evolution of ARS from"wind-cold"dominance to"lung heat"dominance by regulating the p38 mitogen-activated protein kinase(p38 MAPK)/nuclear factor-κB signaling pathway.
方杨;孙炘宸;周辉霞;李惟依;薛珊珊;柏璐;何开元;吴拥军
南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029
医药卫生
鼻渊合剂拆方急性鼻窦炎证型转化风寒肺热
Biyuan HejiDisassembled formulasAcute rhinosinusitisSyndrome transformationWind-coldLung heat
《中国中医基础医学杂志》 2026 (2)
352-359,8
国家自然科学基金面上项目(82174446)
评论